Alexander Gelbard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alexander Gelbard has a total of 608 co-authors. Here are the top co-authors by number of shared publications:
- Alexander T. Hillel
Department of Otolaryngology‐Head and Neck Surgery Johns Hopkins School of Medicine Baltimore Maryland USA
17 shared publications David O. Francis
Department of Surgery, Division of Otolaryngology‐Head and Neck Surgery University of Wisconsin School of Medicine and Public Health Madison Wisconsin U.S.A.
15 shared publicationsChristopher T. Wootten
Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee
11 shared publicationsAlexander T. Hillel
Department of Otolaryngology‐Head & Neck Surgery Johns Hopkins University School of Medicine Baltimore Maryland U.S.A.
10 shared publications- Catherine Gaelyn Garrett
Vanderbilt Voice Center, Vanderbilt University Medical Center, Nashville, Tennessee
9 shared publications - James L. Netterville
Vanderbilt University Medical Center
9 shared publications
Latest Publications
- 1 October 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 395 (13) , 1340-1342
Bilateral Pacing Neuromuscular Prosthesis for Laryngeal Paralysis
- 1 October 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 395 (13) , 1340-1342
Bilateral Pacing Neuromuscular Prosthesis for Laryngeal Paralysis
- Open Access
- 27 August 2026
- Published by Wiley in The Laryngoscope
Therapeutic JAK Inhibition in Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is a fibroinflammatory airway disease causing airway narrowing. Standard treatments are surgical and range from endoscopic procedures to open tracheal resections; there are no adjuvant medical therapies to reduce disease burden. In similar fibroinflammatory diseases such as rheumatoid arthritis (RA), Janus kinase (JAK) inhibitors show great promise in reducing disease severity and recurrence. Therefore, this study sought to identify the potential impact of JAK inhibitors (JAKi) as a novel treatment in iSGS. Methods: A retrospective chart review of over 250 patients with iSGS was conducted at a single institution. Demographic information, timing of medications, adverse reactions, and surgical‐free interval were reviewed. Using the NoAAC iSGS single‐cell RNA sequencing atlas, unsupervised cell clustering was performed, and JAK/STAT pathway activation scores were calculated. Results: Three patients initiated JAKi therapy for RA following diagnosis of iSGS. The mean surgical‐free interval increased from 317 days before to 631 days after JAKi initiation, and the annualized dilation rate decreased from 1.24 to 0.38 dilations per patient‐year. Single‐cell RNA sequencing demonstrated JAK–STAT pathway activation scores were most elevated in iSGS CD4 + T cells and neutrophils, and least activated in epithelial cell subtypes. Gene expression for JAK1 and JAK3 was most active in iSGS immune cell subsets compared to normal controls. Conclusion: Our series of three patients suggests that the JAK/STAT pathway may be a therapeutic target in iSGS. Future investigation exploring the impact of JAKi in prospective clinical trials may be a cornerstone in advancing treatment. Level of Evidence: 4
- 27 August 2026
- Published by Wiley in The Laryngoscope
Open AccessTherapeutic JAK Inhibition in Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is a fibroinflammatory airway disease causing airway narrowing. Standard treatments are surgical and range from endoscopic procedures to open tracheal resections; there are no adjuvant medical therapies to reduce disease burden. In similar fibroinflammatory diseases such as rheumatoid arthritis (RA), Janus kinase (JAK) inhibitors show great promise in reducing disease severity and recurrence. Therefore, this study sought to identify the potential impact of JAK inhibitors (JAKi) as a novel treatment in iSGS. Methods: A retrospective chart review of over 250 patients with iSGS was conducted at a single institution. Demographic information, timing of medications, adverse reactions, and surgical‐free interval were reviewed. Using the NoAAC iSGS single‐cell RNA sequencing atlas, unsupervised cell clustering was performed, and JAK/STAT pathway activation scores were calculated. Results: Three patients initiated JAKi therapy for RA following diagnosis of iSGS. The mean surgical‐free interval increased from 317 days before to 631 days after JAKi initiation, and the annualized dilation rate decreased from 1.24 to 0.38 dilations per patient‐year. Single‐cell RNA sequencing demonstrated JAK–STAT pathway activation scores were most elevated in iSGS CD4 + T cells and neutrophils, and least activated in epithelial cell subtypes. Gene expression for JAK1 and JAK3 was most active in iSGS immune cell subsets compared to normal controls. Conclusion: Our series of three patients suggests that the JAK/STAT pathway may be a therapeutic target in iSGS. Future investigation exploring the impact of JAKi in prospective clinical trials may be a cornerstone in advancing treatment. Level of Evidence: 4
- Open Access
Lymphangiogenesis is Critical for Healing and Survival in a Murine Model of Laryngotracheal Injury
Objective: Lymphatic dysfunction has been implicated in exacerbating fibrosis in numerous diseases, yet the role of the lymphatic system in laryngotracheal injury has not previously been explored. This study aims to evaluate lymphatic vascular remodeling in a murine model of laryngotracheal stenosis (LTS) and determine how pharmacologic blockade of lymphangiogenesis impacts airway healing after mucosal injury. Methods: LTS was induced in C57BL6 mice using an established chemomechanical injury model. Lymphatic density was quantified using LYVE-1 immunohistochemistry. Mice were treated with the VEGFR-3-selective tyrosine kinase inhibitor SAR131675 to block lymphangiogenesis after injury. Outcomes assessed included survival, histopathology, immunohistochemistry, and Evans blue dye vascular leakage. Results: Laryngotracheal injury induced a substaantial increase in subepithelial lymphatic vessel density concomitant with fibrotic remodeling. Pharmacologic inhibition of VEGFR-3 signaling with SAR131675 abrogated this lymphangiogenic response and resulted in markedly increased mortality, impaired epithelial repair with obstructive sloughing, increased edema, and persistent histopathologic evidence of tissue injury. A qualitative increase in pathologic fibrocellular remodeling was also observed, though with no measurable difference in lamina propria thickness. Conclusion: These findings establish lymphatic remodeling as an essential component of successful airway repair following mucosal injury. Lymphatic dysfunction is a common feature of known risk factors for LTS including diabetes, obesity, and prematurity, and can be exacerbated by positive pressure ventilation. Disruption of the lymphangiogenic response to airway injury may lead to stasis of pro-inflammatory factors that result in chronic inflammation, maladaptive remodeling, and pathologic tissue changes. The lymphatic vasculature is a viable target for future mechanistic study and potential therapeutic intervention following airway injury.
Open AccessLymphangiogenesis is Critical for Healing and Survival in a Murine Model of Laryngotracheal Injury
Objective: Lymphatic dysfunction has been implicated in exacerbating fibrosis in numerous diseases, yet the role of the lymphatic system in laryngotracheal injury has not previously been explored. This study aims to evaluate lymphatic vascular remodeling in a murine model of laryngotracheal stenosis (LTS) and determine how pharmacologic blockade of lymphangiogenesis impacts airway healing after mucosal injury. Methods: LTS was induced in C57BL6 mice using an established chemomechanical injury model. Lymphatic density was quantified using LYVE-1 immunohistochemistry. Mice were treated with the VEGFR-3-selective tyrosine kinase inhibitor SAR131675 to block lymphangiogenesis after injury. Outcomes assessed included survival, histopathology, immunohistochemistry, and Evans blue dye vascular leakage. Results: Laryngotracheal injury induced a substaantial increase in subepithelial lymphatic vessel density concomitant with fibrotic remodeling. Pharmacologic inhibition of VEGFR-3 signaling with SAR131675 abrogated this lymphangiogenic response and resulted in markedly increased mortality, impaired epithelial repair with obstructive sloughing, increased edema, and persistent histopathologic evidence of tissue injury. A qualitative increase in pathologic fibrocellular remodeling was also observed, though with no measurable difference in lamina propria thickness. Conclusion: These findings establish lymphatic remodeling as an essential component of successful airway repair following mucosal injury. Lymphatic dysfunction is a common feature of known risk factors for LTS including diabetes, obesity, and prematurity, and can be exacerbated by positive pressure ventilation. Disruption of the lymphangiogenic response to airway injury may lead to stasis of pro-inflammatory factors that result in chronic inflammation, maladaptive remodeling, and pathologic tissue changes. The lymphatic vasculature is a viable target for future mechanistic study and potential therapeutic intervention following airway injury.
- Open Access
- 18 August 2026
- Published by Wiley in The Laryngoscope
Global Multidisciplinary Variation in Idiopathic Subglottic Stenosis Surgical Management
Objective: Idiopathic subglottic stenosis (iSGS) is a rare, fibroinflammatory airway disorder with non‐standardized management. This study aimed to quantify the global clinical variation in surgical strategies for iSGS and identify barriers and facilitators to the adoption of both established and novel techniques. Methods: An international cross‐sectional online survey was responded to by 193 clinicians (otolaryngologists, thoracic surgeons, and interventional pulmonologists) across 42 countries. Data on demographics, technique execution, treatment algorithms, clinician satisfaction (7‐point Likert scale), and adoption barriers were collected. Both statistical analysis and thematic analysis were performed. Results: Otolaryngologists constituted the majority of respondents (84%), predominantly from Europe (52%) and North America (28%). Endoscopic dilation was nearly universal (95%), but execution was heterogeneous (85% used occlusive balloons, 56% used CO 2 laser). Newer techniques showed varied adoption: In‐office serial intralesional steroid injections were used by 57% of clinicians and the Maddern procedure by 17%. Overall satisfaction with current treatment strategies was moderate (mean Likert score: 5.07; SD = 1.15). Significant variation was found in the definition of treatment failure. Fellowship‐trained surgeons managed higher case volumes and were more likely to perform complex open surgery ( p = 0.019). Key barriers to adoption included lack of experience and insufficient supporting evidence. Conclusion: Significant global clinical variation exists in the management of iSGS, affecting surgical technique, adjuvant therapy, and the definition of treatment failure. Standardization of clinical outcomes, continued large‐scale comparative effectiveness trials, and newer efforts aimed at implementing emerging evidence are needed to reduce variability, establish evidence‐based guidelines, and improve global patient care for this complex disease. Level of Evidence: 5.
- 18 August 2026
- Published by Wiley in The Laryngoscope
Open AccessGlobal Multidisciplinary Variation in Idiopathic Subglottic Stenosis Surgical Management
Objective: Idiopathic subglottic stenosis (iSGS) is a rare, fibroinflammatory airway disorder with non‐standardized management. This study aimed to quantify the global clinical variation in surgical strategies for iSGS and identify barriers and facilitators to the adoption of both established and novel techniques. Methods: An international cross‐sectional online survey was responded to by 193 clinicians (otolaryngologists, thoracic surgeons, and interventional pulmonologists) across 42 countries. Data on demographics, technique execution, treatment algorithms, clinician satisfaction (7‐point Likert scale), and adoption barriers were collected. Both statistical analysis and thematic analysis were performed. Results: Otolaryngologists constituted the majority of respondents (84%), predominantly from Europe (52%) and North America (28%). Endoscopic dilation was nearly universal (95%), but execution was heterogeneous (85% used occlusive balloons, 56% used CO 2 laser). Newer techniques showed varied adoption: In‐office serial intralesional steroid injections were used by 57% of clinicians and the Maddern procedure by 17%. Overall satisfaction with current treatment strategies was moderate (mean Likert score: 5.07; SD = 1.15). Significant variation was found in the definition of treatment failure. Fellowship‐trained surgeons managed higher case volumes and were more likely to perform complex open surgery ( p = 0.019). Key barriers to adoption included lack of experience and insufficient supporting evidence. Conclusion: Significant global clinical variation exists in the management of iSGS, affecting surgical technique, adjuvant therapy, and the definition of treatment failure. Standardization of clinical outcomes, continued large‐scale comparative effectiveness trials, and newer efforts aimed at implementing emerging evidence are needed to reduce variability, establish evidence‐based guidelines, and improve global patient care for this complex disease. Level of Evidence: 5.
- Open Access
Voice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study
Objective: Characterize the long‐term vocal outcomes of patients who required ICU care for COVID‐19 infection. Study Design: Prospective cohort study. Setting: Multi‐institutional North American Airway Collaborative Study. Methods: Patients with a COVID‐19 diagnosis requiring ICU admission were identified via ICD‐10 codes and recruited after discharge to complete patient‐reported outcome measures (PROM) in voice (Voice Handicap Index: VHI‐10), communication (Communicative Participation Item Bank: CPIB), and breathing (Clinical COPD Questionnaire: CCQ). Multivariate analysis investigated the association between clinical variables and PROMs. Results: 308 patients enrolled; 271 were admitted with COVID to the ICU. 221 were intubated (81.5%); 50 patients admitted to the ICU did not require intubation (18.5%). Mean follow‐up was 489 days after discharge (95% CI: 452‐526). Mean intubation duration was 17 days (95% CI: 15‐19). Median endotracheal tube (ETT) size was 7.5. Intubation was associated with higher VHI‐10 score (15 vs 10; P = .01) and lower CPIB score (27 vs 30; P < .01). When controlling for ETT size, multivariate analysis did not show a relationship between intubation duration and VHI‐10 or CPIB scores but was associated with worse CCQ score ( P = .04). Conclusion: Survivors of COVID infection requiring ICU admission and intubation have persistent functional impairments in voicing and breathing more than 1 year after their hospitalization. While COVID survivorship and “long COVID” have centered on neuropsychiatric and metabolic outcomes, this study highlights the unappreciated negative impact of endotracheal intubation on voice and communication related to this illness and reinforces the relationship between duration of intubation and subjective dyspnea after surviving critical illness.
Open AccessVoice Outcomes of Patients Intubated for Critical COVID Illness: A Multicenter Study
Objective: Characterize the long‐term vocal outcomes of patients who required ICU care for COVID‐19 infection. Study Design: Prospective cohort study. Setting: Multi‐institutional North American Airway Collaborative Study. Methods: Patients with a COVID‐19 diagnosis requiring ICU admission were identified via ICD‐10 codes and recruited after discharge to complete patient‐reported outcome measures (PROM) in voice (Voice Handicap Index: VHI‐10), communication (Communicative Participation Item Bank: CPIB), and breathing (Clinical COPD Questionnaire: CCQ). Multivariate analysis investigated the association between clinical variables and PROMs. Results: 308 patients enrolled; 271 were admitted with COVID to the ICU. 221 were intubated (81.5%); 50 patients admitted to the ICU did not require intubation (18.5%). Mean follow‐up was 489 days after discharge (95% CI: 452‐526). Mean intubation duration was 17 days (95% CI: 15‐19). Median endotracheal tube (ETT) size was 7.5. Intubation was associated with higher VHI‐10 score (15 vs 10; P = .01) and lower CPIB score (27 vs 30; P < .01). When controlling for ETT size, multivariate analysis did not show a relationship between intubation duration and VHI‐10 or CPIB scores but was associated with worse CCQ score ( P = .04). Conclusion: Survivors of COVID infection requiring ICU admission and intubation have persistent functional impairments in voicing and breathing more than 1 year after their hospitalization. While COVID survivorship and “long COVID” have centered on neuropsychiatric and metabolic outcomes, this study highlights the unappreciated negative impact of endotracheal intubation on voice and communication related to this illness and reinforces the relationship between duration of intubation and subjective dyspnea after surviving critical illness.
- Open Access
- 15 January 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2678-2680
Acromegaly Presenting With Cricoarytenoid Joint Arthropathy
Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.
- 15 January 2026
- Published by Wiley in The Laryngoscope
- Vol. 136 (6) , 2678-2680
Open AccessAcromegaly Presenting With Cricoarytenoid Joint Arthropathy
Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.
- Open Access
- 27 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1920-1927
Inflammatory Markers Stratify Surgical Outcomes in Pediatric Airway Reconstruction
Objectives: Red blood cell distribution width (RDW) predicts surgical success in adult patients undergoing open airway reconstruction for laryngotracheal stenosis, but similar biomarkers in pediatrics remain unidentified. This study identifies predictors of outcomes in pediatric patients undergoing triple endoscopy or surgical airway reconstruction. Methods: A retrospective cohort study of 191 pediatric patients who underwent triple endoscopy or surgical airway reconstruction at an aerodigestive center between 4/18/2013 and 4/17/2023 was completed. Ninety‐eight patients with lab values within 2 months of the procedure were included. Main outcome measures were prosthesis‐free breathing at last follow‐up, hospitalization length, and follow‐up duration. Results: Lower RDW values were associated with prosthesis‐free breathing at last follow‐up ( p = 0.042) and shorter hospitalizations ( p < 0.001). Higher monocyte‐to‐lymphocyte ratio (MLR) and systemic inflammation response indexes (SIRI) correlated with increased length of hospitalization ( p = 0.003 and p = 0.01). Neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and tracheomalacia were associated with longer follow‐up periods ( p = 0.04). Patients with tracheomalacia and OSA prior to intervention were more likely to require tracheostomy at last follow‐up ( p = 0.005 and p = 0.041). Conclusions: RDW may predict long‐term surgical success and outcomes in pediatric patients with complex airway, pulmonary, and upper digestive tract disorders. Serologic markers including SIRI, MLR, NLR, and PLR may also predict outcomes. Patient demographics and surgical type did not correlate with long‐term outcomes, but patients with tracheomalacia and OSA were more likely to require tracheostomy at later time points. Level of Evidence: 3.
- 27 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (4) , 1920-1927
Open AccessInflammatory Markers Stratify Surgical Outcomes in Pediatric Airway Reconstruction
Objectives: Red blood cell distribution width (RDW) predicts surgical success in adult patients undergoing open airway reconstruction for laryngotracheal stenosis, but similar biomarkers in pediatrics remain unidentified. This study identifies predictors of outcomes in pediatric patients undergoing triple endoscopy or surgical airway reconstruction. Methods: A retrospective cohort study of 191 pediatric patients who underwent triple endoscopy or surgical airway reconstruction at an aerodigestive center between 4/18/2013 and 4/17/2023 was completed. Ninety‐eight patients with lab values within 2 months of the procedure were included. Main outcome measures were prosthesis‐free breathing at last follow‐up, hospitalization length, and follow‐up duration. Results: Lower RDW values were associated with prosthesis‐free breathing at last follow‐up ( p = 0.042) and shorter hospitalizations ( p < 0.001). Higher monocyte‐to‐lymphocyte ratio (MLR) and systemic inflammation response indexes (SIRI) correlated with increased length of hospitalization ( p = 0.003 and p = 0.01). Neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), and tracheomalacia were associated with longer follow‐up periods ( p = 0.04). Patients with tracheomalacia and OSA prior to intervention were more likely to require tracheostomy at last follow‐up ( p = 0.005 and p = 0.041). Conclusions: RDW may predict long‐term surgical success and outcomes in pediatric patients with complex airway, pulmonary, and upper digestive tract disorders. Serologic markers including SIRI, MLR, NLR, and PLR may also predict outcomes. Patient demographics and surgical type did not correlate with long‐term outcomes, but patients with tracheomalacia and OSA were more likely to require tracheostomy at later time points. Level of Evidence: 3.
- 27 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3) , 1169-1176
Multi‐Institutional Endoscopic Resection and Reconstitution for Idiopathic Subglottic Stenosis
Objectives: Endoscopic resection and mucosal reconstitution with epidermal grafting (i.e., ER, known as the Maddern procedure) is a minimally invasive surgery introduced 10 years ago to treat subglottic stenosis (SGS). Here we describe a multi‐institutional case series to answer questions about durability, patient selection, and complications. Methods: A retrospective review of idiopathic SGS patients who underwent ER at four institutions since 2016. Patients were stratified by primary definitive (only had previous dilations) and rescue (performed for recurrence after laser wedge resection, open surgery, or previous ER) procedures. Outcomes included complications, disease recurrence, need for tracheostomy, peak expiratory flow rates, and surgery‐free period following the operation. Results: Thirty‐six ER procedures were performed in 33 females and 1 male. Average participant age was 49 (30–72) years and BMI 28.5 (19.1–41.5) kg/m 2 . Seven patients underwent tracheostomy with ER surgery, and five were confirmed to be decannulated afterwards. Recurrence was 21% (6/29) and 71% (5/7) in the primary definitive and rescue cohorts, respectively. Successful ER cases had a long‐term post‐ER surgery free interval of 61.6 months compared to 8.4 months pre‐ER ( p < 0.05), and peak expiratory flow rates of 97% expected post‐ER compared to 55% expected pre‐ER ( p < 0.0005). These peak expiratory flow rates were maintained at 87% expected at last patient follow‐up ( p < 0.0005). Conclusion: This multi‐institutional series demonstrates that the minimally invasive ER procedure, when used as primary definitive surgery, provides durable outcomes for iSGS with a recurrence rate similar to that of open cricotracheal resection over the course of an 8‐year follow‐up period. Level of Evidence: 4.
- 27 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3) , 1169-1176
Multi‐Institutional Endoscopic Resection and Reconstitution for Idiopathic Subglottic Stenosis
Objectives: Endoscopic resection and mucosal reconstitution with epidermal grafting (i.e., ER, known as the Maddern procedure) is a minimally invasive surgery introduced 10 years ago to treat subglottic stenosis (SGS). Here we describe a multi‐institutional case series to answer questions about durability, patient selection, and complications. Methods: A retrospective review of idiopathic SGS patients who underwent ER at four institutions since 2016. Patients were stratified by primary definitive (only had previous dilations) and rescue (performed for recurrence after laser wedge resection, open surgery, or previous ER) procedures. Outcomes included complications, disease recurrence, need for tracheostomy, peak expiratory flow rates, and surgery‐free period following the operation. Results: Thirty‐six ER procedures were performed in 33 females and 1 male. Average participant age was 49 (30–72) years and BMI 28.5 (19.1–41.5) kg/m 2 . Seven patients underwent tracheostomy with ER surgery, and five were confirmed to be decannulated afterwards. Recurrence was 21% (6/29) and 71% (5/7) in the primary definitive and rescue cohorts, respectively. Successful ER cases had a long‐term post‐ER surgery free interval of 61.6 months compared to 8.4 months pre‐ER ( p < 0.05), and peak expiratory flow rates of 97% expected post‐ER compared to 55% expected pre‐ER ( p < 0.0005). These peak expiratory flow rates were maintained at 87% expected at last patient follow‐up ( p < 0.0005). Conclusion: This multi‐institutional series demonstrates that the minimally invasive ER procedure, when used as primary definitive surgery, provides durable outcomes for iSGS with a recurrence rate similar to that of open cricotracheal resection over the course of an 8‐year follow‐up period. Level of Evidence: 4.
- Open Access
- 14 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3) , 1349-1356
The Impact of Estrogen on Stromal Elements in the Proximal Airway in Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is an unexplained fibrosis of the proximal airway that predominantly impacts Caucasian women. Clinically, premenopausal patients suffer from higher recurrence rates, potentially implicating ovarian hormone 17B‐estradiol (E2) in disease pathogenesis. Despite its relationship with disease phenotype and severity, the mechanistic role of E2 in subglottic fibrosis has not been investigated. Methods: Primary human cell lines derived from the airway scar of iSGS patients were utilized for in vitro study to assess the impact of E2 on proximal airway cells (fibroblasts, epithelial cells, and endothelial cells). Alterations in RNA and extracellular matrix protein expression were assessed in fibroblasts ( n = 5 primary cell lines) following E2 exposure. The impact of E2 on epithelial barrier function was assessed via transepithelial electrical resistance measurement (TEER) in iSGS‐patient‐derived epithelial primary cell lines ( n = 3) grown via air–liquid interface (ALI) culture. The impact of E2 on iSGS‐patient‐derived endothelial lines was assessed using a Matrigel‐based tube formation assay. Results: There were no significant transcriptional changes induced in fibroblasts after exposure to E2 when compared to controls, nor was a difference in collagen production observed after E2 exposure. There was no significant difference in TEER measurements in airway epithelial cells grown at ALI following E2 exposure. Endothelial cells showed a significant increase in tube formation following E2 exposure. Conclusion: In vitro models suggest E2 may have limited direct impact on fibroblasts and epithelial cells in iSGS. Instead, estrogen acts directly on airway endothelial cells to drive vascular remodeling, potentially contributing to mucosal fibrosis. Level of Evidence: NA.
- 14 November 2025
- Published by Wiley in The Laryngoscope
- Vol. 136 (3) , 1349-1356
Open AccessThe Impact of Estrogen on Stromal Elements in the Proximal Airway in Idiopathic Subglottic Stenosis
Objectives: Idiopathic subglottic stenosis (iSGS) is an unexplained fibrosis of the proximal airway that predominantly impacts Caucasian women. Clinically, premenopausal patients suffer from higher recurrence rates, potentially implicating ovarian hormone 17B‐estradiol (E2) in disease pathogenesis. Despite its relationship with disease phenotype and severity, the mechanistic role of E2 in subglottic fibrosis has not been investigated. Methods: Primary human cell lines derived from the airway scar of iSGS patients were utilized for in vitro study to assess the impact of E2 on proximal airway cells (fibroblasts, epithelial cells, and endothelial cells). Alterations in RNA and extracellular matrix protein expression were assessed in fibroblasts ( n = 5 primary cell lines) following E2 exposure. The impact of E2 on epithelial barrier function was assessed via transepithelial electrical resistance measurement (TEER) in iSGS‐patient‐derived epithelial primary cell lines ( n = 3) grown via air–liquid interface (ALI) culture. The impact of E2 on iSGS‐patient‐derived endothelial lines was assessed using a Matrigel‐based tube formation assay. Results: There were no significant transcriptional changes induced in fibroblasts after exposure to E2 when compared to controls, nor was a difference in collagen production observed after E2 exposure. There was no significant difference in TEER measurements in airway epithelial cells grown at ALI following E2 exposure. Endothelial cells showed a significant increase in tube formation following E2 exposure. Conclusion: In vitro models suggest E2 may have limited direct impact on fibroblasts and epithelial cells in iSGS. Instead, estrogen acts directly on airway endothelial cells to drive vascular remodeling, potentially contributing to mucosal fibrosis. Level of Evidence: NA.
- 16 July 2025
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 241 (2) , 180-192
Idiopathic Subglottic Stenosis and the Epithelial Interface of Host and Environment
BACKGROUND: Idiopathic subglottic stenosis (iSGS) is a rare fibrotic disease of the proximal airway affecting adult White women nearly exclusively. Life-threatening ventilatory obstruction occurs secondary to pernicious subglottic mucosal scar. Disease rarity and wide geographic patient distribution have previously limited substantive mechanistic investigation into iSGS pathogenesis. STUDY DESIGN: Harnessing pathogenic mucosa from an international iSGS patient cohort and single-cell RNA sequencing, we provide an unbiased characterization of the cell subsets present in the proximal airway scar and detail their molecular phenotypes. RESULTS: Airway epithelium in patients with iSGS is depleted of basal progenitor cells and the residual epithelial cells acquire a mesenchymal phenotype. Observed displacement of bacteria beneath the lamina propria provides functional support for the molecular evidence of epithelial dysfunction. Matched superficial and deep tissue microbiomes support displacement of the native microbiome into the lamina propria of patients iSGS rather than disrupted bacterial community structure. However, animal models confirm that bacteria are necessary for pathologic proximal airway fibrosis and suggest an equally essential role for host adaptive immunity. Human samples from iSGS airway scar demonstrate adaptive immune activation in response to the proximal airway microbiome of both matched patients with iSGS and healthy controls. Clinical outcome data from patients with iSGS suggests that surgical extirpation of airway scar and reconstitution with unaffected tracheal mucosa halts the progressive fibrosis. CONCLUSIONS: Our novel data support an iSGS disease model in which epithelial alterations facilitate microbiome displacement, dysregulated immune activation, and localized fibrosis. Overall, these results refine our understanding of iSGS and implicate shared pathogenic mechanisms with distal airway fibrotic diseases.
- 16 July 2025
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 241 (2) , 180-192
Idiopathic Subglottic Stenosis and the Epithelial Interface of Host and Environment
BACKGROUND: Idiopathic subglottic stenosis (iSGS) is a rare fibrotic disease of the proximal airway affecting adult White women nearly exclusively. Life-threatening ventilatory obstruction occurs secondary to pernicious subglottic mucosal scar. Disease rarity and wide geographic patient distribution have previously limited substantive mechanistic investigation into iSGS pathogenesis. STUDY DESIGN: Harnessing pathogenic mucosa from an international iSGS patient cohort and single-cell RNA sequencing, we provide an unbiased characterization of the cell subsets present in the proximal airway scar and detail their molecular phenotypes. RESULTS: Airway epithelium in patients with iSGS is depleted of basal progenitor cells and the residual epithelial cells acquire a mesenchymal phenotype. Observed displacement of bacteria beneath the lamina propria provides functional support for the molecular evidence of epithelial dysfunction. Matched superficial and deep tissue microbiomes support displacement of the native microbiome into the lamina propria of patients iSGS rather than disrupted bacterial community structure. However, animal models confirm that bacteria are necessary for pathologic proximal airway fibrosis and suggest an equally essential role for host adaptive immunity. Human samples from iSGS airway scar demonstrate adaptive immune activation in response to the proximal airway microbiome of both matched patients with iSGS and healthy controls. Clinical outcome data from patients with iSGS suggests that surgical extirpation of airway scar and reconstitution with unaffected tracheal mucosa halts the progressive fibrosis. CONCLUSIONS: Our novel data support an iSGS disease model in which epithelial alterations facilitate microbiome displacement, dysregulated immune activation, and localized fibrosis. Overall, these results refine our understanding of iSGS and implicate shared pathogenic mechanisms with distal airway fibrotic diseases.